LexDanaLexDanabeta
Inventor

Michael CANNARILE

Inventor
DE

Overview

2→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07KPeptides33%
PatentTitleYear
12,454,573Dosages of emactuzumab202511,498,968Treatment of tumors with an anti-CSF-1R antibody in combination with an anti-PD-L1 antibody after failure of anti-PD-L1/PD1 treatment2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022Patents assigned to HOFFMANN LA ROCHE (1)· patent assignee history
2022–2025Based in DE· patent location history
2025Patents assigned to SYNOX THERAPEUTICS UK LTD (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
HOFFMANN LA ROCHE12022
SYNOX THERAPEUTICS UK LTD12025
Locations
LocationPatentsSpan
DE22022–2025